[Combination therapy of arterial hypertension].
D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D004232:Diuretics; D004311:Double-Blind Method; D004338:Drug Combinations; D005260:Female; D006801:Humans; D006852:Hydrochlorothiazide / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D014290:Metipranolol / Q000008:administration & dosage* / Q000627:therapeutic use; D008875:Middle Aged; D011188:Potassium / Q000097:blood; D011412:Propanolamines / Q000008:administration & dosage*; D012083:Renin / Q000097:blood; D012964:Sodium / Q000097:blood; D049993:Sodium Chloride Symporter Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D004232:Diuretics; D004338:Drug Combinations; D011412:Propanolamines; D049993:Sodium Chloride Symporter Inhibitors; D006852:Hydrochlorothiazide; D012964:Sodium; D012083:Renin; D011188:Potassium; C009732:buthiazide; D014290:Metipranolol
Kombinationstherapie der arteriellen Hypertonie.